BFSG LLC’s DexCom DXCM Stock Holding History

BFSG LLC’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,604	Closed	-$973K	–	198
2022 Q1	$973K	Sell	7,604 -412	-5%	-$45.1K	0.15%	118
2021 Q4	$1.08M	Buy	8,016 +128	+2%	+$18.4K	0.15%	135
2021 Q3	$1.08M	Buy	+7,888	New	+$995K	0.16%	129
2018 Q4	–	Sell	-12,756	Closed	-$456K	–	103
2018 Q3	$456K	Buy	+12,756	New	+$395K	0.19%	106

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFSG LLC's DXCM Position: Q2 2022 in Review

BFSG LLC sold out of DexCom (DXCM) in Q2 2022, closing a stake of 7,604 shares — an estimated $973K sold.

BFSG LLC first reported a position in DXCM in Q3 2018 and held it in 4 quarters. The position peaked at $1.08M in Q3 2021. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

BFSG LLC reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
BFSG LLC sold 7,604 DexCom shares in Q2 2022, an estimated $973K.
BFSG LLC first reported a position in DexCom in Q3 2018 and held it in 4 quarters.
BFSG LLC's DexCom position peaked at $1.08M in Q3 2021.
798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on BFSG LLC's 13F filing for Q2 2022, filed 4 Aug 2022.